Rhonda Patrick· PhD
This is still largely correlative data. But when you combine a large risk reduction with a dose-dependent trend, it becomes hard to ignore.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
This is still largely correlative data. But when you combine a large risk reduction with a dose-dependent trend, it becomes hard to ignore.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
for every 100 mg/day increase in omega-3 intake, Alzheimer’s disease and cognitive decline risk falls by about 10%.
So for every increase in so 100 millgram per day increase in omega-3 fatty acids that was associated with lowering the risk of Alzheimer's disease and cognitive decline by 10%.